Shandong Total Cash From Operating Activities from 2010 to 2025

600529 Stock   24.60  0.41  1.64%   
Shandong Pharmaceutical's Total Cash From Operating Activities is increasing over the years with slightly volatile fluctuation. Overall, Total Cash From Operating Activities is expected to go to about 1.3 B this year. From 2010 to 2025 Shandong Pharmaceutical Total Cash From Operating Activities quarterly data regression line had arithmetic mean of  520,464,026 and r-squared of  0.74. View All Fundamentals
 
Total Cash From Operating Activities  
First Reported
2001-12-31
Previous Quarter
210.6 M
Current Value
205.7 M
Quarterly Volatility
115 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Shandong Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shandong Pharmaceutical's main balance sheet or income statement drivers, such as Interest Expense of 512.3 K, Selling General Administrative of 177.4 M or Total Revenue of 6 B, as well as many indicators such as . Shandong financial statements analysis is a perfect complement when working with Shandong Pharmaceutical Valuation or Volatility modules.
  
This module can also supplement various Shandong Pharmaceutical Technical models . Check out the analysis of Shandong Pharmaceutical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Shandong Stock

Shandong Pharmaceutical financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Pharmaceutical security.